Clinical and electrophysiologic outcome in patients with neovascular glaucoma treated with and without bevacizumab. [electronic resource]
Producer: 20121004Description: 563-74 p. digitalISSN:- 1724-6016
- Aged
- Aged, 80 and over
- Angiogenesis Inhibitors -- administration & dosage
- Antibodies, Monoclonal, Humanized -- administration & dosage
- Bevacizumab
- Combined Modality Therapy
- Electrophysiology
- Electroretinography
- Female
- Glaucoma, Neovascular -- drug therapy
- Humans
- Intravitreal Injections
- Laser Coagulation
- Male
- Photoreceptor Cells, Vertebrate -- physiology
- Prospective Studies
- Retina -- physiopathology
- Retinal Vein Occlusion -- drug therapy
- Treatment Outcome
- Vascular Endothelial Growth Factor A -- antagonists & inhibitors
- Visual Acuity -- physiology
No physical items for this record
Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.